Medically reviewed by Dr. Giovanni Scornavacca — Hair Restoration Specialist, Carisma Hair Clinic, St Julian's, Malta. 20+ years clinical experience, trained in Rome and Bologna.

Medically reviewed by Dr. Giovanni Scornavacca — Hair Restoration Specialist, Carisma Hair Clinic, St Julian's, Malta. 20+ years clinical experience.

Finasteride vs Minoxidil in Malta: Which Treatment Is Right for You?

Finasteride and minoxidil work through entirely different mechanisms and suit different patients. For most men with androgenetic alopecia, finasteride addresses the hormonal root cause while minoxidil stimulates follicle activity independently. Clinical guidelines increasingly recommend both in combination. The right choice depends on your specific loss pattern, stage, and medical history.

You have probably spent time reading about both. You know the names, you have seen the statistics, and you are now at the point where you need to make a decision — or at least understand what a properly qualified recommendation would look like. That is a reasonable place to be.

The problem is that most online comparisons flatten the nuance. They present finasteride and minoxidil as interchangeable alternatives when they are not. They differ in mechanism, in who they suit, in what side effects to expect, and in how long results take to appear. For anyone considering hair loss treatment Malta patients have access to both — but using the right one for your specific pattern determines whether the next 12 months brings measurable improvement or frustrating stagnation.

This guide covers both medications in clinical detail: how they work, what the evidence shows, who each suits, what they cost in Malta, and when combining them is the better approach. Results may vary for each individual, and a clinical assessment is always recommended before starting any treatment.

Contents

• ›At a Glance: Finasteride vs Minoxidil Comparison Table
• ›How Finasteride Works
• ›How Minoxidil Works
• ›Evidence Comparison: What the Clinical Data Shows
• ›Who Should Take Finasteride
• ›Who Should Take Minoxidil
• ›The Case for Combining Both
• ›Cost Comparison in Malta
• ›Timeline: What to Expect and When
• ›When Neither Is Enough: The Role of PRP and Clinical Protocols
• ›The Malta-Specific Gap: Why Self-Prescribing Carries Real Risk
• ›Frequently Asked Questions About Finasteride vs Minoxidil in Malta

At a Glance: Finasteride vs Minoxidil Comparison Table

How Finasteride Works

Finasteride targets the hormonal mechanism that drives androgenetic alopecia at its source.

Testosterone is converted into dihydrotestosterone (DHT) by an enzyme called 5-alpha reductase, predominantly type II. DHT binds to androgen receptors in genetically susceptible hair follicles and progressively shortens the growth cycle with each successive phase — a process called follicular miniaturisation. Over months and years, hairs become thinner, shorter, and eventually stop growing altogether.

Finasteride selectively inhibits type II 5-alpha reductase, reducing serum DHT by approximately 71% and scalp DHT by approximately 64% at the standard 1 mg oral dose. This was demonstrated in a 249-participant randomised controlled trial that remains foundational to the medication's evidence base (Kaufman et al., 1998 — original finasteride RCT, NEJM). By reducing the DHT signal at the follicle level, finasteride slows or halts the miniaturisation process.

It does not directly stimulate hair growth. What it does is remove the hormone that was causing follicle suppression — and in doing so, allows follicles that were miniaturising (but not yet dormant) to recover. Clinical evidence indicates that approximately 83% of men showed no further hair loss at the crown over two years, and approximately 61–66% achieved visible regrowth at the vertex. Frontal area response is more modest — approximately 37% at one year. The evidence is strongest for crown and mid-scalp.

For detail on accessing this medication, see the full guide on getting finasteride in Malta.

How Minoxidil Works

Minoxidil's mechanism is distinct and, in some respects, complementary to finasteride.

It is a potassium channel opener that acts on vascular smooth muscle, producing vasodilation and increased blood flow to the dermal papilla — the structure at the base of the follicle that controls hair growth. This enhanced circulation prolongs the anagen (growth) phase of the hair cycle and appears to increase follicle size, producing thicker, longer hairs. It also shortens the telogen (resting) phase, allowing dormant follicles to re-enter active growth more quickly.

An important point for new users: when minoxidil forces resting follicles back into the growth phase, the old telogen hairs are physically displaced and shed first. This is the shedding phase some patients experience in the first two to eight weeks — a recognised, temporary effect and generally a positive sign that the medication is biologically active.

Evidence suggests that in a 48-week randomised controlled trial of 393 men, 74.2% showed improvement in hair density with 5% topical minoxidil by investigator assessment (Olsen et al. — topical minoxidil efficacy review). The 5% formulation produces approximately 45% more non-vellus hair regrowth than the 2% formulation in men, based on direct head-to-head RCT data. Clinical evidence consistently supports minoxidil as an effective standalone treatment — and a highly effective partner to finasteride.

{width="1200" height="630" loading="eager"} Photo by www.kaboompics.com via Pexels. Choosing the right hair loss treatment requires a proper clinical assessment, not guesswork.

Evidence Comparison: What the Clinical Data Shows

Both medications have robust, multi-decade evidence bases — but they address different parts of the same problem.

Finasteride has the strongest evidence for slowing and stabilising androgenetic alopecia in men. The pivotal long-term placebo-controlled trials, replicated and reviewed in numerous independent studies, consistently show stabilisation rates above 80% at two years and meaningful regrowth at the crown in the majority of users. A systematic review of the evidence base confirms the benefit is statistically significant, particularly at 12 weeks, with sustained effects through long-term use (Adil & Godwin, 2017 — systematic review of finasteride for androgenetic alopecia).

Minoxidil has similarly strong evidence for improving hair density, with benefit shown in both 2% and 5% formulations across multiple RCTs. It also has the advantage of working independently of the androgenic pathway — meaning it is effective in both men and women, and in hair loss not driven purely by DHT.

Combination therapy is where the strongest evidence now sits. A 2025 meta-analysis of seven RCTs confirmed that combining topical minoxidil and finasteride produces significantly greater improvements in hair density, hair diameter, and global assessment scores than either medication alone. For men with androgenetic alopecia, most specialist clinical guidance now recommends combination therapy as the standard of care — not a choice between one or the other.

Who Should Take Finasteride

Finasteride is the preferred first-line medication for men with confirmed androgenetic alopecia — male pattern hair loss driven by DHT sensitivity in genetically predisposed follicles.

Finasteride is most appropriate for:

• ›Men with androgenetic alopecia at Norwood stages I through IV, particularly those with crown thinning or diffuse mid-scalp loss
• ›Men who want to address the hormonal cause of hair loss, not just stimulate surface growth
• ›Men willing to commit to long-term, continuous use (results require sustained treatment)
• ›Men who have had hair transplantation and want to prevent further native hair loss

Finasteride is not appropriate for:

• ›Women who are pregnant, may become pregnant, or are breastfeeding. This is an absolute contraindication. Finasteride is teratogenic — it causes dose-dependent abnormalities in male fetal genital development. Women who are pregnant must not handle crushed or broken tablets.
• ›Women of childbearing age in general, unless under strict medical supervision with appropriate contraception. There is no licensed indication for finasteride in premenopausal women.
• ›Men with non-androgenetic causes of hair loss, where DHT is not the driving factor.

Approximately 2–5% of men taking oral finasteride report sexual side effects including decreased libido, erectile dysfunction, or ejaculation changes. These typically resolve after stopping the medication. A small number of patients have reported effects persisting after discontinuation — a phenomenon sometimes discussed in the literature as post-finasteride syndrome; the current medical evidence on this is still developing, and anyone with concerns should discuss them with their prescribing physician before starting treatment.

If you want to understand the potential side effects in more depth, see our dedicated guide: finasteride side effects Malta.

The topical formulation with fewer systemic effects is an alternative for men who want comparable efficacy with reduced systemic DHT suppression.

Who Should Take Minoxidil

Minoxidil has a broader indication than finasteride — it is appropriate for both men and women, and for a wider range of hair loss types.

Minoxidil is most appropriate for:

• ›Men with androgenetic alopecia at any Norwood stage, particularly those who want visible results in a shorter initial timeframe
• ›Women with female pattern hair loss or diffuse thinning (2% is the standard licensed female formulation; 5% is sometimes prescribed off-label for women under medical supervision)
• ›Patients who cannot take finasteride due to contraindications
• ›Patients who want to use it as a complement to finasteride for additive benefit

Who should take particular care:

• ›Women who are pregnant or breastfeeding should consult a physician before using any minoxidil formulation
• ›Patients with cardiovascular conditions — minoxidil's vasodilatory properties may have systemic effects, particularly with oral minoxidil
• ›Anyone experiencing scalp irritation from the propylene glycol in solution formulations may prefer foam

Low-dose oral minoxidil is an emerging option supported by growing clinical evidence. Evidence suggests a 2025 systematic review of 27 studies and over 2,900 patients found meaningful improvement in the majority of users. The most common side effect is hypertrichosis (unwanted hair growth on the face or body), affecting approximately one-third of users. Oral minoxidil is an off-label use requiring a prescription and medical supervision.

The Case for Combining Both

For men with androgenetic alopecia, the clinical argument for combining finasteride and minoxidil is compelling.

Finasteride addresses the cause — reducing the DHT signal that drives follicle miniaturisation. Minoxidil addresses the consequence — stimulating follicle activity and prolonging the growth cycle independently of DHT. These mechanisms do not overlap. They operate in parallel, which is why combination therapy consistently outperforms either monotherapy in head-to-head trials.

Practically, combining them means one medication is working on your hormonal environment while the other is actively promoting blood flow and follicle health. The 2025 meta-analysis of seven RCTs found statistically and clinically significant advantages for the combination across density, diameter, and global hair counts.

Many patients at Carisma Hair Clinic arrive having tried one medication in isolation for 12 months without satisfactory results — when the evidence-supported approach would have been to use both from the outset. Getting the combination right, and monitoring it with scalp imaging, is where the meaningful difference is made.

Cost Comparison in Malta

Understanding the cost of each treatment is part of making a sustainable decision, since both require continuous use.

Finasteride in Malta:

• ›Requires a valid prescription from a licensed medical professional
• ›Branded Propecia (1 mg finasteride): approximately €30–40 per month
• ›Generic finasteride: approximately €15–25 per month, available through licensed pharmacies
• ›Topical finasteride formulations: typically priced within a similar range, depending on supplier and concentration

Minoxidil in Malta:

• ›Lower-concentration formulations (2%) are available over the counter in pharmacies
• ›5% topical minoxidil (foam or solution): approximately €20–40 per month, OTC or via prescription
• ›Low-dose oral minoxidil: requires a prescription; pricing varies

Combination therapy:

• ›At approximately €35–80 per month depending on formulations and whether branded or generic products are used, combination therapy remains cost-accessible relative to the scale of benefit it provides. Compare this to the cost of surgical hair restoration, which typically begins at several thousand euros.

The larger cost is not financial — it is the cost of starting the wrong treatment, or starting the right one too late in the progression of loss. For a full cost breakdown, see our guides on getting finasteride in Malta and getting minoxidil in Malta.

Timeline: What to Expect and When

Neither medication produces results quickly. Setting realistic expectations is important for treatment adherence.

Finasteride timeline:

• ›Months 1–3: No visible change. DHT is being suppressed, the hormonal environment is shifting, but hair cycle changes are not yet apparent
• ›Months 3–6: Some patients notice reduced shedding. Hair that was in the process of miniaturising begins to stabilise
• ›Months 6–12: Stabilisation is typically apparent. Some patients begin to see early regrowth, particularly at the crown
• ›Months 12–24: Peak regrowth benefit. Most clinical trials measure primary endpoints at 24 months

Minoxidil timeline:

• ›Weeks 2–8: Some patients experience initial shedding as dormant hairs are displaced — this is expected and temporary
• ›Months 3–4: Early improvement in density may be visible; individual variation is significant
• ›Months 6–12: Full initial response becomes apparent
• ›Ongoing: Benefits require continuous application — gains reverse within 6–12 months of stopping

Important framing: Minoxidil may show earlier cosmetic results than finasteride, but finasteride is addressing the underlying driver that minoxidil is not. Stopping finasteride returns the DHT environment to baseline; stopping minoxidil removes the active growth stimulation. Both require long-term commitment. Your Norwood stage affects which is better for you and how quickly you may see results.

{width="1200" height="630" loading="lazy"} Photo by www.kaboompics.com via Pexels. Both medications require consistent, continuous use to maintain results.

When Neither Is Enough: The Role of PRP and Clinical Protocols

For some patients — typically those at more advanced Norwood stages, or those who have not responded adequately to medication — topical finasteride and minoxidil alone are insufficient.

This is where PRP hair treatment Malta and structured clinical protocols become relevant. Platelet-rich plasma (PRP) therapy uses concentrated growth factors from the patient's own blood to directly stimulate follicle activity at the cellular level. A peer-reviewed meta-analysis confirmed PRP produces a 25–40% improvement in density metrics over six months (Giordano et al., 2018 — PRP meta-analysis, Journal of the American Academy of Dermatology). Its mechanism is distinct from both finasteride and minoxidil — making it a further layer in a comprehensive protocol rather than a replacement for medication.

The Hair Reset Protocol at Carisma Hair Clinic integrates scalp imaging and density mapping diagnostics, targeted prescription treatment, and where appropriate, PRP or exosome therapy within a 90-day structured programme. Average density increase measured by scalp imaging is 21–28% after 90 days. The programme accepts 12 patients per month — not for artificial scarcity, but because each patient receives direct clinical supervision from Dr. Giovanni Scornavacca throughout.

The Malta-Specific Gap: Why Self-Prescribing Carries Real Risk

This is the section of this comparison that most online resources omit, and it matters for anyone researching finasteride vs minoxidil Malta specifically.

Finasteride and minoxidil are both available through online pharmacies — some operating with minimal or no medical oversight. It is not difficult to obtain either without a clinical assessment. The problem is not access. The problem is appropriateness.

Both medications behave differently depending on your pattern of loss, your Norwood stage, your hormonal profile, and whether your hair loss is truly androgenetic in origin. Treating diffuse thinning from an iron deficiency or thyroid condition with finasteride achieves nothing and delays the correct diagnosis by 12 months or more. Treating a woman of childbearing age with finasteride carries genuine medical risk.

A patient who starts minoxidil for crown loss when the clinical picture actually calls for finasteride plus minoxidil, and who waits 12 months for results that never arrive, is a patient whose treatable window has narrowed. Hair follicles in late miniaturisation do not recover.

Getting a proper diagnosis — with scalp imaging, pattern assessment, and medical history review — is not optional for making the right treatment decision. It is the treatment decision.

Frequently Asked Questions About Finasteride vs Minoxidil in Malta

Is finasteride or minoxidil better for hair loss?

Neither is universally better — they work differently and suit different situations. Finasteride addresses the hormonal cause of androgenetic alopecia by reducing DHT, while minoxidil stimulates follicle activity independently of hormones. For men with male pattern baldness, clinical evidence strongly supports using both together. For women, minoxidil is appropriate; finasteride is not recommended for women of childbearing age. A clinical assessment is necessary to determine which is right for your specific pattern.

Can I take finasteride and minoxidil together in Malta?

Yes. Combination therapy is supported by multiple RCTs and is increasingly considered the evidence-based standard of care for androgenetic alopecia. A 2025 meta-analysis of seven randomised controlled trials confirmed the combination produces significantly greater improvements in hair density and diameter than either treatment alone. Both can be prescribed by a licensed physician in Malta, and they work on non-overlapping pathways — making their combined effect additive, not redundant.

How long does it take to see results with finasteride vs minoxidil?

Minoxidil typically shows earlier initial signs — some improvement in density can be measurable at three to four months, after an initial shedding phase of two to eight weeks. Finasteride acts more slowly: stabilisation is often apparent at six months, with peak regrowth effect measured at 18–24 months in most clinical trials. Starting one treatment and abandoning it after four months because results are not visible is one of the most common reasons patients lose the most treatable window of their hair loss.

Is minoxidil available without a prescription in Malta?

Lower-concentration minoxidil formulations (typically 2%) are available over the counter at pharmacies in Malta. The 5% concentration, which clinical evidence shows produces approximately 45% more regrowth than 2% in men, is available through licensed pharmacies and may require a prescription depending on the product and pharmacy. Low-dose oral minoxidil requires a prescription and medical supervision regardless. Finasteride at any dose requires a prescription in Malta.

Do I need a prescription for finasteride in Malta?

Yes. Finasteride is a prescription-only medication in Malta. You cannot legally purchase it over the counter or through unregulated online sources without a valid prescription from a licensed physician. This is appropriate given finasteride's hormonal mechanism and its absolute contraindication for women of childbearing age. A clinical assessment also ensures you are treating the correct type of hair loss.

How much do finasteride and minoxidil cost in Malta?

Generic finasteride in Malta costs approximately €15–25 per month; branded Propecia is approximately €30–40 per month. Minoxidil 5% topical costs approximately €20–40 per month. Combination therapy runs approximately €35–80 per month depending on whether you use branded or generic versions. This is considerably lower than surgical hair restoration, which typically begins at several thousand euros. Both treatments are ongoing costs, since results reverse when treatment is stopped.

Is finasteride safe for long-term use?

The long-term safety profile of finasteride at 1 mg is well established across 30+ years of clinical use. The most commonly reported side effects — occurring in approximately 2–5% of men — are sexual in nature and typically resolve on stopping the medication. Finasteride is not safe for use by women of childbearing potential under any circumstances. Anyone considering long-term use should discuss their individual health history with a prescribing physician.

What happens if I stop taking finasteride or minoxidil?

Both treatments must be used continuously to maintain results. Stopping finasteride allows DHT levels to return to baseline, and miniaturisation typically resumes within months. Studies show that approximately 60% of minoxidil users experience recurrence within one year of stopping, with around 80% experiencing recurrence within two years. Some studies suggest hair counts after stopping can fall below pre-treatment baseline. The commitment to ongoing treatment should factor into your decision from the outset.

Making the Right Decision for Your Pattern

The comparison between finasteride and minoxidil matters — but it is not the first question to answer. The first question is: what is the correct diagnosis, and what is the pattern and stage of your loss?

From there, the evidence is fairly clear. For most men with androgenetic alopecia, the best-supported approach involves both medications used together, with regular monitoring to assess response. For women, minoxidil under medical guidance is the primary option. For patients with more advanced loss or incomplete response to medication, clinical protocols combining prescription treatment with PRP or exosome therapy offer measurable additional benefit.

At Carisma Hair Clinic in St Julian's, each patient begins with a 45-minute clinical assessment that includes scalp imaging and density mapping. Dr. Giovanni Scornavacca reviews your specific pattern, medical history, and goals before making any treatment recommendation. There is no single-size answer — and we do not offer one.

If you have been researching finasteride and minoxidil and want a recommendation tailored to your exact situation, the right next step is a clinical conversation, not another comparison article.

Ready to Take Control of Your Hair Loss?

If you've been researching your options and want a clinical assessment rather than another generic recommendation, Carisma Hair Clinic offers a comprehensive diagnostic consultation — scalp imaging, density mapping, and a personalised protocol designed around your specific pattern of loss.

→ Book Your Free Hair Loss Consultation

Dr. Giovanni Scornavacca and the team at Carisma Hair Clinic are available at our St Julian's clinic.

About the Author

Dr. Giovanni Scornavacca is a hair restoration specialist with over 20 years of clinical experience, with advanced training at universities in Rome and Bologna. He leads the Hair Reset Protocol at Carisma Hair Clinic — Malta's most complete non-surgical hair regrowth programme. Dr. Scornavacca specialises in diagnosing and treating androgenetic alopecia, telogen effluvium, and complex hair loss presentations using a combination of PRP, exosome therapy, and prescription protocols tailored to each patient.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Results may vary for each individual. Always consult a qualified healthcare professional before starting any hair loss treatment. Finasteride is a prescription-only medication in Malta and must not be used or handled by women who are pregnant or may become pregnant. Minoxidil must be used consistently and continuously to maintain results. Oral minoxidil is an off-label use requiring a prescription. Dr. Giovanni Scornavacca and Carisma Hair Clinic are available for clinical consultation at our St Julian's, Malta clinic.

Written and reviewed by Dr. Giovanni Scornavacca, Carisma Hair Clinic. Published: 26 June 2026.

Ready to Take Action?

Book a free consultation with Dr. Giovanni Scornavacca to get a personalised hair loss assessment and treatment plan.